Work

Analytical method development and validation of emtricitabine, bictegravir, tenofovir alafenamide by RP-HPLC

Year: 2020
Type: article
Abstract: A simple and precise method was developed for estimating Emtricitabine, Bictegravir and Tenofovir Alafenamide. The method was found to be specific and precise. The separation was attained on Symmetry C18 (150 × 4.5mm, 5µm)column with Water : Acetonitrile : Methanol (15:35:50) % v/v as mobile phase at a flow rate of 1.0 ml/min and linearity was achieved in the concentration range of 50% to 150% of standard concentration with correlation coefficient 0.99. The percent recovery from the assay was found to be 100.80%for Emtricitabine, 100.34% for Bictegravirand 100.64% for Tenofovir Alafenamide. Specificity and precision studies for Emtricitabine, Bictegravir and Tenofovir Alafenamide were within the acceptable range. From the stability studies, the percentage variation was less than 10.0% which is the desired criteria. Therefore, this method can be adopted to estimate Emtricitabine, Bictegravir and Tenofovir Alafenamidein other pharmaceutical formulations.
Language: English
Field: Chemistry
Open Access status: diamond
OpenAlex ID: W7220480355
FWCI:
Cites: 15
Cited by:
Related to: 10